BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIVI BioVie Inc

交易中 07-22 15:04:03 EDT

0.3933

+0.0078

+2.02%

最高0.3999	最低0.3802	成交量21.98万
今开0.3850	昨收0.3855	日振幅5.11%
总市值2,404万	流通市值1,452万	总股本6,112万
成交额8.58万	换手率0.60%	流通股本3,693万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":0.3933,"timestamp":1721674926409,"preClose":0.3855,"halted":0,"volume":219846,"delay":0,"floatShares":36930083,"shares":61116761,"eps":-0.953947,"marketStatus":"交易中","marketStatusCode":2,"change":0.0078,"latestTime":"07-22 15:04:03 EDT","open":0.385,"high":0.3999,"low":0.3802,"amount":85754.78400192,"amplitude":0.051102,"askPrice":0.3954,"askSize":1300,"bidPrice":0.3915,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.953947,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":0.3855,"preHourTrading":{"tag":"盘前","latestPrice":0.4099,"preClose":0.3855,"latestTime":"09:20 EDT","volume":1003,"amount":409.49145998,"timestamp":1721654448789},"postHourTrading":{"tag":"盘后","latestPrice":0.385,"preClose":0.3855,"latestTime":"19:16 EDT","volume":3208,"amount":1244.8191,"timestamp":1721430961991},"volumeRatio":0.732858,"impliedVol":1.7183,"impliedVolPercentile":0.5219},"requestUrl":"/m/hq/s/BIVI","defaultTab":"news","newsList":[{"id":"2450464108","title":"Biovie Inc.盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450464108","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450464108?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:49","pubTimestamp":1720633755,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日01时49分，Biovie Inc.股票出现异动，股价急速上涨5.10%。截至发稿，该股报0.431美元/股，成交量9.3746万股，换手率0.15%，振幅4.75%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110149159681b982&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110149159681b982&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","VRPX","BIVI"],"gpt_icon":0},{"id":"2448986488","title":"Biovie Inc.盘中异动 股价大涨7.27%报0.434美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448986488","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448986488?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013477,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分，Biovie Inc.股票出现波动，股价大幅拉升7.27%。截至发稿，该股报0.434美元/股，成交量4.6806万股，换手率0.08%，振幅3.14%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131179efc1aa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131179efc1aa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2448104359","title":"背景资料-礼来紧随百健-艾赛之后，获得美国食品及药物管理局对阿尔茨海默氏症药物的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2448104359","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448104359?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:18","pubTimestamp":1720009106,"startTime":"0","endTime":"0","summary":"     路透7月3日 -    礼来公司  的Kisunla周二获得了美国食品和药物管理局的标准批准，用于减缓阿尔茨海默氏症的进展。Kisunla是继百健  和日本卫材  的Leqembi之后，第二种获得美国监管机构传统批准的治疗脑萎缩疾病的药物，这在一个经历了多次失败的领域是一个重要的里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1988902786.USD","IE0002141913.USD","LU2237443978.SGD","CGTX","GB00BDT5M118.USD","IE00B894F039.SGD","ANVS","LU0122379950.USD","LU1804176565.USD","BK4534","IE00B1BXHZ80.USD","LU0882574055.USD","LU0289739699.SGD","LU2237443382.USD","LU0079474960.USD","LU2237443549.SGD","LU0256863811.USD","BIIB","LU2491049909.HKD","LU2491050071.SGD","BK4007","IE00BJJMRZ35.SGD","LU2237438978.USD","LU2468319806.SGD","LU1057294990.SGD","LU2264538146.SGD","LU0708995401.HKD","LGVN","LU0320765992.SGD","LU1023059063.AUD","IE0004445239.USD","COYA","BK4533","LU0943347566.SGD","LU1551013342.USD","LU1280957306.USD","LU2237443622.USD","IE00B19Z9P08.USD","LU1551013425.SGD","LU0058720904.USD","LU1814569148.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","BK7067","ACIU","ACW.AU","BIVI","LLY","LU0109391861.USD"],"gpt_icon":0},{"id":"2443675911","title":"Biovie Inc.盘中异动 早盘股价大跌5.00%报0.462美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675911","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443675911?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:53","pubTimestamp":1718373215,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时53分，Biovie Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报0.462美元/股，成交量2.7525万股，换手率0.05%，振幅4.46%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421533596814507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421533596814507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGVN","BIVI"],"gpt_icon":0},{"id":"2441778364","title":"Biovie Inc.盘中异动 临近收盘股价大涨5.69%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441778364","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441778364?lang=zh_cn&edition=full","pubTime":"2024-06-06 04:01","pubTimestamp":1717617695,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日04时01分，Biovie Inc.股票出现波动，股价急速拉升5.69%。截至发稿，该股报0.490美元/股，成交量34.239万股，换手率0.56%，振幅6.28%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606040136aef39487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606040136aef39487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2439575800","title":"Biovie Inc.盘中异动 股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439575800","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439575800?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:24","pubTimestamp":1716992653,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时24分，Biovie Inc.股票出现异动，股价大幅下跌5.74%。截至发稿，该股报0.426美元/股，成交量8.1629万股，换手率0.13%，振幅4.54%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为1.18%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529222414aef25792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529222414aef25792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2438930575","title":"Biovie Inc.盘中异动 早盘股价大跌5.02%报0.431美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438930575","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438930575?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:34","pubTimestamp":1716906880,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日22时34分，Biovie Inc.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报0.431美元/股，成交量24.1791万股，换手率0.40%，振幅5.72%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为1.74%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。BIV201有可能改善数千名因肝炎、非酒精性脂肪性肝炎和酗酒而患有危及生命的肝硬化并发症的患者的健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528223441aef21cc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528223441aef21cc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2431867516","title":"Biovie Inc.盘中异动 早盘快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431867516","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431867516?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:30","pubTimestamp":1714401001,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时30分，Biovie Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报0.510美元/股，成交量68.0805万股，换手率1.24%，振幅4.06%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292230027a573103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292230027a573103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2429145269","title":"Biovie Inc.盘中异动 急速拉升5.77%报0.511美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429145269","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429145269?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:13","pubTimestamp":1713896035,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时13分，Biovie Inc.股票出现异动，股价快速拉升5.77%。截至发稿，该股报0.511美元/股，成交量33.5858万股，换手率0.61%，振幅5.59%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.64%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240213567a54f514&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240213567a54f514&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2429978245","title":"Biovie Inc.盘中异动 股价大跌5.04%报0.462美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429978245","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429978245?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:04","pubTimestamp":1713798252,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时04分，Biovie Inc.股票出现波动，股价快速跳水5.04%。截至发稿，该股报0.462美元/股，成交量20.4682万股，换手率0.37%，振幅3.66%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.12%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222304127a549b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222304127a549b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2428591112","title":"Biovie Inc.盘中异动 早盘股价大涨7.98%报0.509美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428591112","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428591112?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:31","pubTimestamp":1713447070,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时31分，Biovie Inc.股票出现波动，股价快速上涨7.98%。截至发稿，该股报0.509美元/股，成交量65.774万股，换手率1.20%，振幅1.97%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182131108b363914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182131108b363914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2427830006","title":"Biovie Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427830006","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427830006?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:30","pubTimestamp":1713187833,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时30分，Biovie Inc.股票出现波动，股价急速上涨5.00%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为575.22%、327.00%、246.66%，振幅较大的相关个股有Pluri Inc.、Cg Oncology, Inc.、Cel-Sci Corporation，振幅分别为6.96%、5.19%、4.91%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041521303379209ec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041521303379209ec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","BIVI"],"gpt_icon":0},{"id":"2426736530","title":"Biovie Inc.盘中异动 股价大涨5.23%报0.521美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426736530","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426736530?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:34","pubTimestamp":1712932464,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日22时34分，Biovie Inc.股票出现波动，股价大幅上涨5.23%。截至发稿，该股报0.521美元/股，成交量25.5267万股，换手率0.46%，振幅9.93%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222342479203c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222342479203c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2426910302","title":"Biovie Inc.盘中异动 股价大涨5.06%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426910302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426910302?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:08","pubTimestamp":1712862493,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时08分，Biovie Inc.股票出现异动，股价急速上涨5.06%。截至发稿，该股报0.490美元/股，成交量42.003万股，换手率0.76%，振幅4.63%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041203081387e7fafd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041203081387e7fafd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2425356309","title":"Biovie Inc.盘中异动 股价大跌5.13%报0.466美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425356309","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425356309?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:40","pubTimestamp":1712324432,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时40分，Biovie Inc.股票出现波动，股价急速下挫5.13%。截至发稿，该股报0.466美元/股，成交量10.258万股，换手率0.19%，振幅5.13%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052140327a5113d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052140327a5113d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2424828844","title":"Biovie Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424828844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424828844?lang=zh_cn&edition=full","pubTime":"2024-04-03 22:14","pubTimestamp":1712153661,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日22时14分，Biovie Inc.股票出现波动，股价大幅下跌5.06%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃，换手率分别为388.51%、274.34%、40.34%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.，振幅分别为69.52%、53.80%、42.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032214217a50f9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032214217a50f9dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2420472686","title":"Biovie Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472686","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420472686?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:49","pubTimestamp":1710769776,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时49分，Biovie Inc.股票出现异动，股价急速下挫5.00%。截至发稿，该股报0.670美元/股，成交量17.8849万股，换手率0.33%，振幅5.35%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318214936791b35b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318214936791b35b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","IMRX","BK4539","BK4139","BK4563"],"gpt_icon":0},{"id":"2419607304","title":"Biovie Inc.盘中异动 早盘快速下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607304","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419607304?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:49","pubTimestamp":1710424150,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时49分，Biovie Inc.股票出现异动，股价急速下跌5.42%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142149117a4cb684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142149117a4cb684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2419768095","title":"Biovie Inc.盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419768095","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419768095?lang=zh_cn&edition=full","pubTime":"2024-03-13 22:10","pubTimestamp":1710339032,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日22时10分，Biovie Inc.股票出现波动，股价大幅拉升5.57%。截至发稿，该股报0.699美元/股，成交量34.3862万股，换手率0.63%，振幅5.03%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313221033791a1c46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313221033791a1c46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2418065553","title":"Biovie Inc.盘中异动 快速下挫5.02%报0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418065553","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418065553?lang=zh_cn&edition=full","pubTime":"2024-03-12 22:17","pubTimestamp":1710253037,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日22时17分，Biovie Inc.股票出现异动，股价急速跳水5.02%。截至发稿，该股报0.660美元/股，成交量39.3089万股，换手率0.72%，振幅4.99%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031222171787e78363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031222171787e78363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioviepharma.com","stockEarnings":[{"period":"1week","weight":-0.1688},{"period":"1month","weight":-0.141},{"period":"3month","weight":-0.2076},{"period":"6month","weight":-0.6916},{"period":"1year","weight":-0.9237},{"period":"ytd","weight":-0.694}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioVie Inc.成立于2013年4月10日，是一家内华达州公司。该公司是一家临床阶段的公司，致力于开发创新药物疗法，以治疗慢性衰弱疾病，包括神经和神经退行性疾病以及肝脏疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.024941},{"month":2,"riseRate":0.5,"avgChangeRate":0.343428},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.007393},{"month":4,"riseRate":0.333333,"avgChangeRate":0.031293},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.1608},{"month":6,"riseRate":0.571429,"avgChangeRate":0.512357},{"month":7,"riseRate":0.571429,"avgChangeRate":0.414984},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.107609},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.163736},{"month":10,"riseRate":0.333333,"avgChangeRate":0.067701},{"month":11,"riseRate":0.5,"avgChangeRate":0.012606},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.089981}],"exchange":"NASDAQ","name":"BioVie Inc","nameEN":"BioVie Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioVie Inc,BIVI,BioVie Inc股票,BioVie Inc股票老虎,BioVie Inc股票老虎国际,BioVie Inc行情,BioVie Inc股票行情,BioVie Inc股价,BioVie Inc股市,BioVie Inc股票价格,BioVie Inc股票交易,BioVie Inc股票购买,BioVie Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}